High impact
Medical Policy and Coding Updates - August 2026
Premera Blue Cross·Effective Nov 15, 2026
This comprehensive August 2026 policy update from Carelon Medical Benefits Management affects genetic testing, somatic tumor testing, radiation oncology, and antipsychotic medications effective November 15, 2026. Major changes include expanded coverage for liquid biopsy testing in multiple cancer types, new non-medical necessity designations for specific tests, revised radiation oncology guidelines for non-malignant conditions, and updated criteria for hematologic malignancy testing. Billing teams must update prior authorization requirements, coverage determination logic, and clinical appropriateness screening across oncology, genetic testing, and radiation oncology services.